Novartis Pharmaceuticals Corp. is recalling 792 cartons of Promacta (eltrombopag) 12.5 mg for Oral Suspension. This prescription drug is being recalled because it may have been cross-contaminated with peanut flour during the manufacturing process. Consumers who are allergic to peanuts should not use this medication as it could cause a severe allergic reaction.
The product may contain trace amounts of peanut flour due to cross-contamination at the manufacturing facility. Individuals with a peanut allergy who consume this product could experience life-threatening anaphylaxis or other serious allergic reactions.
Drug recall remedy
“Photo of Promacta 12.5mg oral suspension”
“Alternate Photo of Promacta 12.5mg oral suspension”
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · FDA Press Release · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.